Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER (PFE)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Pfizer : inks tech deal with VN company

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/12/2019 | 03:49am EST

Pharmaceutical company Pfizer announced on Thursday it has signed a deal with Medochemie to transfer technology to manufacture its innovative medicines in Vit Nam.

Pfizer said it would bring its global technologies and operations platforms of hard-to-make products such as sterile injectables to Vit Nam and help raise local manufacturing standards to that of international markets.

Under the agreement, Medochemie, which has a plant in Bnh Dng Province, will make Pfizers anti-infective, cardiovascular, and pain drugs.

Commenting on the partnership, Bradley Allen Silcox, chief representative of Pfizer Thailand in Vit Nam, said: We are grateful to the Ministry of Health of Vit Nam and the Government of Vit Nam for their vision to improve the capacity and capability of the pharmaceutical sector, and for creating an eco-stem that allows patients the quality of care and treatment.

Daphne Pittas, director of Medochemie, said: This partnership gives an impetus to Vit Nams pharmaceutical industry capability for the manufacture of complex medicines such as oral dosages and injectable cephalosporin.

Medochemie strongly believes in and will continue to support the scientific and technological advancement of the Vietnamese pharmaceutical sector.

Vit Nam is a rapidly developing market with a population of 95 million as of 2017. Steady economic growth and an expansion of the middle income have increased demand for high-quality healthcare goods and services, especially medicines, the two companies said in press release.

(c) 2003-2019 SudanTribune - All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PFIZER
04:36aBeiGene's Btk inhibitor gets U.S. breakthrough designation
AQ
04:10aPFIZER : US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat ..
AQ
01/14PFIZER : FDA Accepts NDAs for Tafamidis in ATTR-CM
DJ
01/14PFIZER : US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat ..
BU
01/12PFIZER : inks tech deal with VN company
AQ
01/12PFIZER : CytoReason teams with Pfizer on drug discovery
AQ
01/11PFIZER : Statement of Changes in Beneficial Ownership
PU
01/10AMERISOURCEBERGEN : US government recovered $2.5B from Medicare, Medicaid fraud ..
AQ
01/10PFIZER : to stop manufacturing in its Chennai and Aurangabad facilities
AQ
01/10AMERISOURCEBERGEN : US government recovered $2.5B from Medicare, Medicaid fraud ..
AQ
More news
Financials ($)
Sales 2018 53 590 M
EBIT 2018 20 023 M
Net income 2018 13 007 M
Debt 2018 28 504 M
Yield 2018 3,23%
P/E ratio 2018 17,73
P/E ratio 2019 17,53
EV / Sales 2018 5,12x
EV / Sales 2019 5,03x
Capitalization 246 B
Chart PFIZER
Duration : Period :
Pfizer Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 45,3 $
Spread / Average Target 7,0%
EPS Revisions
Managers
NameTitle
Albert Bourla Director, Chief Executive & Operating Officer
Ian C. Read Executive Chairman
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
W. Don Cornwell Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER-1.76%245 746
JOHNSON & JOHNSON0.54%344 044
ROCHE HOLDING LTD.4.13%221 817
NOVARTIS1.59%221 313
MERCK AND COMPANY-3.98%190 790
AMGEN1.08%125 392